| Literature DB >> 32934627 |
Hussam A Alharbi1, Monirah A Albabtain2, Nourah Alobiad3, Jomanah Aba Alhasan3, Maram Alruhaimi3, Muzun Alnefisah3, Samar Alateeq3, Haneen Alghosoon4, Sumaiah J Alarfaj5, Amr A Arafat6,7, Khaled D Algarni6,8.
Abstract
BACKGROUND: Pain management remains an integral part of patient care after cardiac surgery, and it required proper pain assessment. The aim of the study was to assess pain perception using validated Arabic version of the short-form McGill Pain Questionnaire (SF-MPQ) and to identify analgesics prescribing patterns post cardiac surgery.Entities:
Keywords: McGill pain questionnaire; pain assessment; post-sternotomy pain
Year: 2020 PMID: 32934627 PMCID: PMC7458021 DOI: 10.4103/sja.SJA_34_20
Source DB: PubMed Journal: Saudi J Anaesth
Patients’ characteristics
| Variable ( | Frequency (%)/mean±SD |
|---|---|
| Age (years) | 57±11 |
| Male | 47 (63.5) |
| Weight (kg) | 76±12.9 |
| Height (meter) | 1.6±0.1 |
| Body mass index (Kg/m2) | 35.5±11.6 |
| Previous cardiac surgery | 19 (25.7) |
| Heart failure | 7 (9.5) |
| Ischemic heart disease | 31 (41.9) |
| Rheumatic heart disease | 9 (12) |
| Atrial Fibrillation | 8 (10.8) |
| Hypertension | 41 (55) |
| Diabetes mellitus | 26 (35) |
| Insulin-dependent diabetes | 16 (21.6) |
| Dyslipidemia | 27 (36.5) |
| Hemoglobin (mg/dL) | 12.7±3 |
| Bilirubin (µmol/L) | 8±6 |
| Creatinine (µmol/L) | 106.6±150.8 |
| Renal impairment | |
| Moderate (CrCl >50 and <85) | 29 (39.2) |
| Severe (CrCl <50) | 8 (10.8) |
| Smoker | 8 (10.8) |
| Ex-smoker | 9 (12) |
| Surgery | |
| CABG | 24 (32.4) |
| Valves only | 37 (50) |
| CABG + valves | 9 (12) |
| Others* | 4 (5) |
Continuous variables are presented as mean and standard deviation and categorical variables as number and percent CABG: Coronary artery bypass graft; CrCl: Creatinine clearance. *Others=Pericardiectomy, repair of aortic dissection, heart transplant
Pre-procedure medications
| Variable ( | Frequency (%) |
|---|---|
| Beta-blockers | 54 (73) |
| Angiotensin receptor blockers | 10 (13.5) |
| Calcium channel blockers | 12 (16) |
| Angiotensin-converting enzyme inhibitors | 20 (27) |
| Thiazide diuretics | 3 (4) |
| Loop diuretics | 36 (48.6) |
| Digitalis | 2 (2.7) |
| Antiplatelet | 53 (71.6) |
| Anticoagulants | 16 (21.6) |
| Statins | 36 (48.6) |
Data are presented as number and percent
Descriptors of the patient’s pain experience on the sensory and affective subscales of pain sensation
| Descriptors of pain | Severe | Moderate | Mild | Total- experience | No pain |
|---|---|---|---|---|---|
| Sensory subscale | |||||
| Throbbing | 7 (9.5) | 4 (5.4) | 2 (2.7) | 13 (17.6) | 61 (82.4) |
| Shooting | 3 (4.1) | 4 (5.4) | 1 (1.4) | 8 (10.8) | 66 (89.2) |
| Stabbing | 14 (18.9) | 8 (10.8) | 4 (5.4) | 26 (35.1) | 48 (64.9) |
| Sharp | 12 (16.2) | 8 (10.8) | 5 (6.8) | 25 (33.8) | 49 (66.2) |
| Cramping | 6 (8.1) | 8 (10.8) | 7 (9.5) | 21 (28.4) | 53 (71.6) |
| Gnawing | 0 | 4 (5.4) | 4 (5.4) | 8 (10.8) | 66 (89.2) |
| Hot-burning | 7 (9.5) | 4 (5.4) | 7 (9.5) | 18 (24.3) | 56 (75.7) |
| Aching | 11 (14.9) | 6 (8.1) | 8 (10.8) | 25 (33.8) | 49 (66.2) |
| Heavy | 17 (23) | 14 (18.9) | 6 (8.1) | 37 (50) | 37 (50) |
| Tender | 8 (10.8) | 9 (12.2) | 4 (5.4) | 21 (28.4) | 53 (71.6) |
| Splitting | 11 (14.9) | 4 (5.4) | 6 (8.1) | 21 (28.4) | 53 (71.6) |
| Affective subscale | |||||
| Tiring-exhausting | 21 (28.4) | 17 (23) | 11 (14.9) | 49 (66.2) | 25 (33.8) |
| Sickening | 7 (9.5) | 5 (6.8) | 10 (13.5) | 22 (29.7) | 52 (70.3) |
| Fearful | 5 (6.8) | 0 | 5 (6.8) | 10 (13.5) | 64 (86.5) |
| Punishing-cruel | 14 (18.9) | 7 (9.5) | 5 (6.8) | 26 (35.1) | 48 (64.9) |
Data are presented as number and percent
Pain intensity as measured by the short-form McGill Pain Questionnaire (SF-MPQ)
| McGill pain questionnaire ( | Day 1 | Day 2 | |
|---|---|---|---|
| PRI | 7 IQR (2.8,15) | 5 (2,11) | 0.010 |
| NRS | 6 IQR (3,8) | 5 (2,8) | 0.021 |
| PPI | |||
| No Pain | 5 (6.8) | 12 (16) | <0.001 |
| Mild | 16 (21.6) | 19 (25.7) | |
| Discomforting | 17 (23) | 26 (35) | |
| Distressing | 6 (8) | 4 (5) | |
| Horrible | 20 (27) | 10 (13.5) | |
| Excruciating | 10 (13.5) | 3 (4) | |
| Pain Description | |||
| No Pain | 5 (6.8) | 11 (14.9) | 0.521 |
| Brief | 7 (9.5) | 4 (5) | |
| Intermittent | 44 (59.5) | 37 (50) | |
| Continuous | 18 (24) | 22 (29.7) |
Data are presented as number and percent. NRS: Numerical rating scale; PRI: Pain rating index
Figure 1Baseline pain intensity scores of post-cardiac surgery patients according to gender
Figure 2(a) Pain location and (b) pain aggregating factors of patients post-surgery
Pain medication administration pattern
| Pain medication strategy | Frequency and percentage of patients per pain management strategy | |
|---|---|---|
| Day 1 | Day 2 | |
| No pain medications | 7 (9.5) | 10 (13.5) |
| Single drug (oral) | 2 (2.7) | 8 (10.8) |
| Single drug (parenteral) | 31 (41.9) | 31 (41.9) |
| Multimodal (2 medications) | 33 (44.6) | 25 (33.8) |
| Multimodal (3 medications) | 1 (1.4) | 0 |
Data are presented as number and percent